# | Title | Journal | Year | Citations |
---|
1 | NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors | Journal of the National Comprehensive Cancer Network: JNCCN | 2010 | 1,004 |
2 | Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 994 |
3 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 943 |
4 | Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2020 | 848 |
5 | Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 762 |
6 | Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2016 | 760 |
7 | Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 758 |
8 | Hepatobiliary Cancers | Journal of the National Comprehensive Cancer Network: JNCCN | 2009 | 719 |
9 | Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 707 |
10 | Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 700 |
11 | Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 698 |
12 | NCCN Guidelines Insights: Colon Cancer, Version 2.2018 | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 675 |
13 | Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 672 |
14 | Prostate Cancer | Journal of the National Comprehensive Cancer Network: JNCCN | 2010 | 671 |
15 | Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2020 | 633 |
16 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 628 |
17 | Non–Small Cell Lung Cancer | Journal of the National Comprehensive Cancer Network: JNCCN | 2010 | 606 |
18 | Cancer-Related Fatigue, Version 2.2015 | Journal of the National Comprehensive Cancer Network: JNCCN | 2015 | 581 |
19 | Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 564 |
20 | Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2022 | 562 |
21 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020 | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 556 |
22 | Prostate Cancer, Version 1.2016 | Journal of the National Comprehensive Cancer Network: JNCCN | 2016 | 544 |
23 | Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2022 | 530 |
24 | Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 498 |
25 | Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 488 |
26 | Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 477 |
27 | Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 476 |
28 | Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 457 |
29 | Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 451 |
30 | Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2022 | 445 |
31 | Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 443 |
32 | NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018 | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 439 |
33 | Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 432 |
34 | Gastric Cancer, Version 2.2013 | Journal of the National Comprehensive Cancer Network: JNCCN | 2013 | 422 |
35 | Distress Management Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2003 | 420 |
36 | Colon Cancer | Journal of the National Comprehensive Cancer Network: JNCCN | 2009 | 409 |
37 | NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 | Journal of the National Comprehensive Cancer Network: JNCCN | 2017 | 408 |
38 | Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal | Journal of the National Comprehensive Cancer Network: JNCCN | 2020 | 401 |
39 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018 | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 394 |
40 | Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 393 |
41 | Breast Cancer | Journal of the National Comprehensive Cancer Network: JNCCN | 2009 | 389 |
42 | Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2019 | 385 |
43 | Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2020 | 383 |
44 | The NCCN Guideline for Distress Management: A Case for Making Distress the Sixth Vital Sign | Journal of the National Comprehensive Cancer Network: JNCCN | 2007 | 377 |
45 | NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines | Journal of the National Comprehensive Cancer Network: JNCCN | 2007 | 360 |
46 | Non–Small Cell Lung Cancer, Version 2.2013 | Journal of the National Comprehensive Cancer Network: JNCCN | 2013 | 357 |
47 | Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2022 | 357 |
48 | Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology | Journal of the National Comprehensive Cancer Network: JNCCN | 2021 | 356 |
49 | Non–Small Cell Lung Cancer | Journal of the National Comprehensive Cancer Network: JNCCN | 2008 | 343 |
50 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016 | Journal of the National Comprehensive Cancer Network: JNCCN | 2016 | 335 |